Hyloris Sets Out Plans To Expand Its Pipeline
Value Added Medicines Company Aims For 14 Commercial Products By 2024
After partnering with companies like Purna Female Healthcare and AFT Pharmaceuticals, Belgian value-added medicines specialist Hyloris has announced plans to add three new products to its pipeline in the coming months with a goal of having 14 commercial products by 2024.
